dalteparin has been researched along with Acute Cholecystitis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galimov, OV | 1 |
| Galeev, FS | 1 |
| Khanov, VO | 1 |
| Mukhametov, AR | 1 |
| Andreev, PP | 1 |
| Muslimova, LR | 1 |
| Aminova, LN | 1 |
1 other study available for dalteparin and Acute Cholecystitis
| Article | Year |
|---|---|
[Some aspects of abdominal surgical interventions in the presence of obesity].
Topics: Anticoagulants; Cholecystitis, Acute; Female; Follow-Up Studies; Hernia, Diaphragmatic; Hernia, Vent | 2008 |